Wyeth stockholders approve acquisition by Pfizer
MADISON, N.J. Wyeth stockholders have approved the company’s acquisition by Pfizer, Wyeth announced Monday.
The drug maker said more than 98% of shares voted in favor of the merger, which the company’s board approved earlier this year amid a wave of large-scale pharmaceutical company mergers.
“The merger is in the best interests of our company and our stockholders,” Wyeth chairman, president and CEO Bernard Poussot said in a statement. “Combined with Pfizer, we see opportunities for increased scale where needed and resources to become the world’s first premier biopharmaceutical company and an industry leader in human, consumer and animal health care.”
Chews-4-Health to be featured on TV show
WILMINGTON, N.C. Chews-4-Health on Friday announced that its super fruit/sea vegetable/antioxidant chewable dietary supplement will be the featured nutritional product on the upcoming television show “Kids Spaces”. The “Focus on Healthy Children” special will air nationally on the Woman’s Entertainment Network July 24 and on The Learning Channel July 25.
Chews-4-Health provides 13 servings of fruits and vegetables and contains no chemical preservatives, artificial sweeteners, dyes or unnatural flavors. The chewable tablets are made from whole food fruits and vegetables.
“Chews-4-Health helps parents across the country give their children the very best nutritious dietary supplements,” stated David Friedman, product formulator and CEO of Chews-4-Health. “It is an honor to be featured on ‘Kids Spaces’ as the nutritional product of choice, and I hope many parents tune in to the show and get this valuable information.”
WHO to stop disclosing global tables of confirmed H1N1 cases; will continue to document pandemic
GENEVA The World Health Organization announced on Thursday it would no longer provide the global tables showing the numbers of confirmed cases for all countries. However, as part of continued efforts to document the global spread of the H1N1 pandemic, regular updates will be provided describing the situation in the newly affected countries.
“At this point, further spread of the pandemic, within affected countries and to new countries, is considered inevitable,” WHO stated. “The 2009 influenza pandemic has spread internationally with unprecedented speed. In past pandemics, influenza viruses have needed more than six months to spread as widely as the new H1N1 virus has spread in less than six weeks,” making it extremely difficult for countries to try and confirm novel H1N1 infections through laboratory testing.
The novel H1N1 pandemic has been characterized, to date, by the mildness of symptoms in the overwhelming majority of patients, who usually recover, even without medical treatment, within a week of the onset of symptoms, WHO stated. But countries still need to be on guard for signals indicating a more virulent, or more deadly strain, such as spikes in rates of absenteeism from schools or workplaces or a surge in emergency department visits.